Drug Research

Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. Fenofibrate Capsules, which are generic equivalent to Lupin Atlantis Holdings' Antara Capsules, are indicated as...

Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As part of the deal, both the firms will evaluate anti-cancer drug conjugate by using Spirogen's...

Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the deal, UCB and ConfometRx will leverage structural biology to gain insight into G-protein coupled receptor...

Dr. Reddy's Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets (ODT) in 2.5mg and 5mg strengths in the US. Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), which...

Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing. The land-based aquaculture system is designed to support multiple generations of all stages of Megathura crenulata's life...

Synthon Biopharmaceuticals has opened a GMP antibody-drug conjugate (ADC) production facility in Nijmegen. The Nijmegen facility will produce ADCs, which combine specific anti-cancer antibody or antibody fragment to an anti-cancer therapeutic, required for Phase...

Specialty pharmaceutical company Paladin Labs has introduced first allergen immunotherapy tablet, Oralair, against grass pollen allergies in Canada. The sublingual once daily medication should be administered from four months prior to the onset of...